企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
SyntekaBio,Inc. is a bio venture company established in September 2009 that engages mainly in developing AI drug discovery platform services based on technology that processes three-dimensional protein structure and genomic big data, the most critical elements in new drug development, as well as developing its own drug pipelines. In particular, in 2014, the company gained experience with the supercomputing and big data infrastructure that laid the groundwork for its platform service development, through a supercomputing technology investment from the Electronics and Telecommunications Research Institute (ETRI), a commissioned research project with the Next-Generation Personalized Medicine Genome Project, and participation in the International Cancer Genome Consortium's whole-genome cancer analysis project.
代表理事
Jung Jongseon
成立日期
2009年9月15日
法人类型
韩国创业板
行业分类
Software publishing
法人注册号
11011-4179457
营业执照号
105-87-35732
电话号码
070-7663-0958
传真号码
02-6280-0984
公司地址
18 Gukjegwahak 17-ro, Yuseong-gu, Daejeon
产品与服务
评论